Economic Evaluation of Posaconazole Versus Fluconazole or Itraconazole in the Prevention of Invasive Fungal Infection in High-Risk Neutropenic Patients in Sweden

被引：0
|
作者：
Johan Lundberg
Martin Höglund
Magnus Björkholm
Örjan Åkerborg
机构：
[1] MSD Sweden (AB),Outcomes Research
[2] University Hospital,Division of Hematology, Department of Medical Science
[3] Karolinska University Hospital Solna,Department of Medicine
[4] Optum Insight,undefined
来源：
Clinical Drug Investigation | 2014年 / 34卷
关键词：
Acute Myeloid Leukemia; Fluconazole; Itraconazole; Invasive Aspergillosis; Acute Myeloid Leukemia Patient;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：483 / 489
页数：6
相关论文
共 50 条
  • [41] Prevention of invasive fungal infections in patients with acute myeloid leukaemia: results of a single centre retrospective observational study with the use of posaconazole versus conventional mould-active azoles
    Dellacasa, Chiara Maria
    Busca, Alessandro
    Audisio, Ernesta
    Marmont, Filippo
    Barbui, Anna Maria
    Falda, Michele
    De Rosa, Francesco Giuseppe
    Frairia, Chiara
    Allione, Bernardino
    D'Ardia, Stefano
    Aydin, Semra
    Pecoraro, Clara
    Manetta, Sara
    Vitolo, Umberto
    JOURNAL OF CHEMOTHERAPY, 2014, 26 (05) : 315 - 320
  • [42] Economic evaluation of azoles as primary prophylaxis for the prevention of invasive fungal infections in Spanish patients undergoing allogeneic haematopoietic stem cell transplant
    Solano, Carlos
    Slavin, Monica
    Shaul, Alissa J.
    Marks, David I.
    Cordonnier, Catherine
    Cornely, Oliver A.
    Pagliuca, Antonio
    Cragin, Lael
    Jarque, Isidro
    Garcia-Vidal, Carolina
    Sorensen, Sonja
    Vanness, David J.
    Charbonneau, Claudie
    Andoni Barrueta, Jon
    Peral, Carmen
    De Salas-Cansado, Marina
    Bow, Eric J.
    MYCOSES, 2017, 60 (02) : 79 - 88
  • [43] Evaluation of posaconazole plasma concentrations achieved with the delayed-release tablets in Korean high-risk patients with haematologic malignancy
    Chae, Hyojin
    Cho, Sung-Yeon
    Yi, Yunmi
    Lee, Jeong Joong
    Cha, Kyoungho
    Kim, Myungshin
    Kim, Yonggoo
    Kim, Yoo-Jin
    Kim, Hee-Je
    Lee, Dong-Gun
    MYCOSES, 2020, 63 (02) : 131 - 138
  • [44] High- versus low-dose fluconazole therapy for empiric treatment of suspected invasive candidiasis among high-risk patients in the intensive care unit: a cost-effectiveness analysis
    Chen, Hua
    Suda, Katie J.
    Turpin, Robin S.
    Pai, Manjunath P.
    Bearden, David T.
    Garey, Kevin W.
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (05) : 1057 - 1065
  • [45] Antifungal Prophylaxis and Treatment of Breakthrough Invasive Fungal Diseases in High-Risk Hematology Patients: A Prospective Observational Multicenter Study
    Metan, Goekhan
    Ciftcioglu, Ayse
    Saba, Rabin
    Kilic, Ayseguel Ulu
    Ozdemir, Kevser
    Cag, Yasemin
    Unal, Demet Kiper
    Aksoy, Firdevs
    Berk, Hande
    Mert, Gurkan
    Tunccan, Ozlem Guzel
    Tombak, Anil
    Balkan, Ilker Inanc
    Cavus, Sema Alp
    Kandemir, Bahar
    Mutlu, Birsen
    Inkaya, Ahmet Cagkan
    Kaynar, Leylagul
    Atay, Memis Hilmi
    Dursun, Fadime Ersoy
    Saydam, Guray
    Unsal, Yakup
    Sari, Simge Fidan
    Akan, Hamdi
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2025, 41 (01) : 75 - 88
  • [46] Performance, Correlation and Kinetic Profile of Circulating Serum Fungal Biomarkers of Invasive Aspergillosis in High-Risk Patients with Hematologic Malignancies
    Siopi, Maria
    Karakatsanis, Stamatis
    Roumpakis, Christoforos
    Korantanis, Konstantinos
    Eldeik, Elina
    Sambatakou, Helen
    Sipsas, Nikolaos V.
    Tsirigotis, Panagiotis
    Pagoni, Maria
    Meletiadis, Joseph
    JOURNAL OF FUNGI, 2021, 7 (03)
  • [47] Comment on "Prevention of severe Candida infections in non-neutropenic, high-risk, critically ill patients," by Garbino et al.
    H. K. F. van Saene
    L. Silvestri
    A. Petros
    M. Viviani
    M. A. de la Cal
    D. F. Zandstra
    Intensive Care Medicine, 2003, 29 : 1192 - 1193
  • [48] Real-World Use of Isavuconazole as Primary Therapy for Invasive Fungal Infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant
    Dagher, Hiba
    Hachem, Ray
    Chaftari, Anne-Marie
    Jiang, Ying
    Ali, Shahnoor
    Deeba, Rita
    Shah, Shivan
    Raad, Issam
    JOURNAL OF FUNGI, 2022, 8 (01)
  • [49] A pilot study of targeted itraconazole prophylaxis in patients with graft-versus-host disease at high risk of invasive mould infections following allogeneic stem cell transplantation
    A P Grigg
    M Brown
    A W Roberts
    J Szer
    M A Slavin
    Bone Marrow Transplantation, 2004, 34 : 447 - 453
  • [50] A pilot study of targeted itraconazole prophylaxis in patients with graft-versus-host disease at high risk of invasive mould infections following allogeneic stem cell transplantation
    Grigg, AP
    Brown, M
    Roberts, AW
    Szer, J
    Slavin, MA
    BONE MARROW TRANSPLANTATION, 2004, 34 (05) : 447 - 453
12345